2Xideas’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-31,089
| Closed | -$12.6M | – | 54 |
|
|
2023
Q4 | $12.6M | Sell |
31,089
-3,870
| -11% | -$1.57M | 1.36% | 29 |
|
|
2023
Q3 | $12.2M | Sell |
34,959
-2,098
| -6% | -$730K | 1.35% | 21 |
|
|
2023
Q2 | $13M | Buy |
37,057
+576
| +2% | +$203K | 1.25% | 25 |
|
|
2023
Q1 | $11.5M | Buy |
36,481
+2,521
| +7% | +$794K | 1.11% | 38 |
|
|
2022
Q4 | $9.81M | Buy |
33,960
+1,776
| +6% | +$513K | 1.04% | 49 |
|
|
2022
Q3 | $9.32M | Sell |
32,184
-17,424
| -35% | -$5.05M | 0.98% | 27 |
|
|
2022
Q2 | $14M | Sell |
49,608
-22,157
| -31% | -$6.24M | 1.28% | 14 |
|
|
2022
Q1 | $18.7M | Sell |
71,765
-8,461
| -11% | -$2.21M | 1.32% | 13 |
|
|
2021
Q4 | $17.6M | Buy |
80,226
+23,363
| +41% | +$5.13M | 1.06% | 21 |
|
|
2021
Q3 | $10.3M | Buy |
56,863
+12,692
| +29% | +$2.3M | 0.79% | 61 |
|
|
2021
Q2 | $8.91M | Buy |
44,171
+8,097
| +22% | +$1.63M | 0.8% | 62 |
|
|
2021
Q1 | $7.75M | Buy |
36,074
+5,210
| +17% | +$1.12M | 0.86% | 59 |
|
|
2020
Q4 | $7.29M | Buy |
+30,864
| New | +$7.29M | 0.91% | 19 |
|